Cancer family · grouped by EvidenceHelix from study titles

Breast: 32 studies

Public cancer genomics studies in this group, with the collection each belongs to. Open a study for its description, citation and original source links.

• Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)

  Whole exome sequencing of 12 breast AdCCs.

  BreastMSK studiesSource code acbcPubMed 1

• Breast Cancer (HTAN, 2022)

  An omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical meta…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)

  Targeted sequencing of 2509 primary breast tumors with 548 matched normals.

  BreastOther published and consortium studiesSource code brcaPubMed 3

• Breast Cancer (MSK, Cancer Cell 2018)

  Targeted Sequencing of tumor/normal sample pairs from 1918 Breast cancers.

  BreastMSK studiesSource code breastPubMed 1

• Breast Cancer (MSK, Clinical Cancer Res 2020)

  Whole-exome and MSK-IMPACT sequencing of 60 tumor/normal matched samples.

  BreastMSK studiesSource code brcaPubMed 1

• Breast Cancer (MSK, Nature Cancer 2020)

  Targeted sequencing of pre- and post-treatment tumor/cfDNA samples from 51 Breast Cancer patients to understand the mechanisms of resistance to Alepelisib.

  BreastMSK studiesSource code breastPubMed 1

• Breast Cancer (MSK, NPJ Breast Cancer 2019)

  Targeted Sequencing of buparlisib + letrozole and alpelisib + letrozole-treated metastatic ER+ unmatched breast tumors.

  BreastMSK studiesSource code brcaPubMed 1

• Breast Cancer (SMC 2018)

  Whole-exome sequencing of 187 primary tumors from a Korean breast cancer cohort (SMC).

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer Xenografts (British Columbia, Nature 2015)

  Whole genome/targeted sequencing to evaluate the clonal dynamics in 116 breast cancer patient xenografts.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Fibroepithelial Tumors (Duke-NUS, Nat Genet 2015)

  Whole exome sequencing of 22 phyllodes tumors

  BreastOther published and consortium studiesSource code bfnPubMed 1

• Breast Invasive Carcinoma (British Columbia, Nature 2012)

  Whole genome/exome sequencing analysis of 65 breast cancer samples

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Invasive Carcinoma (Broad, Nature 2012)

  Whole-exome sequencing of 103 breast cancer tumor/normal sample pairs. Generated by the Broad Institute.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Invasive Carcinoma (Sanger, Nature 2012)

  Whole exome sequencing from 100 breast cancer tumor/normal sample pairs. Generated by the Sanger Institute.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Invasive Carcinoma (TCGA, Cell 2015)

  Whole-exome sequencing of 817 Breast Invasive Carcinoma tumor/normal pairs. The Cancer Genome Atlas (TCGA) Breast Invasive Carcinoma Project.

  BreastTCGA (other releases)Source code brcaPubMed 1

• Breast Invasive Carcinoma (TCGA, Firehose Legacy)

  TCGA Breast Invasive Carcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/BRCA/20160128/). Previously known as TCGA Provisional.

  BreastTCGA Firehose LegacySource code brca

• Breast Invasive Carcinoma (TCGA, Nature 2012)

  Whole-exome sequencing (510 samples with matched normals), genomic DNA copy number arrays, DNA methylation, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays analysis on 825 primary breast can…

  BreastTCGA (other releases)Source code brcaPubMed 1

• Breast Invasive Carcinoma (TCGA, PanCancer Atlas)

  Breast Invasive Carcinoma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratla…

  BreastTCGA PanCancer AtlasSource code brcaPubMed 12

• Breast Invasive Lobular Carcinoma (MSK, NPJ Precis Oncol 2024)

  Targeted Sequencing of 25 breast invasive lobular carcinoma tumors lacking CDH1 bi-allelic genetic alterations, and their matched normals via MSK-IMPACT.

  BreastMSK studiesSource code breastPubMed 1

• Juvenile Papillomatosis and Breast Cancer (MSK,J Pathol. 2015)

  Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma.

  BreastMSK studiesSource code brcaPubMed 1

• MAPK on resistance to anti-HER2 therapy for breast cancer (MSK, Nat Commun. 2022)

  MSK-IMPACT targeted sequencing of 145 breast tumors with matched normal samples.

  BreastMSK studiesSource code brcaPubMed 1

• Metaplastic Breast Cancer (MSK,NPJ Breast Cancer 2021)

  Targeted or whole-exome sequencing of 19 Metaplastic Breast Cancer tumor/normal pairs.

  BreastMSK studiesSource code mbcPubMed 1

• Metastatic Breast Cancer (AURORA US Network, Nat Cancer 2023)

  Whole exome and low-pass whole genome sequencing of 55 patients with metastatic breast cancer (53 primary cancers and 102 metastases) and their matched normals. Retrospective Tissue Collection; an initiative of the Br…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Metastatic Breast Cancer (DFCI, Cancer Discov 2020)

  Whole exome sequencing of 59 CDK4/6i exposed metastatic breast cancer tumors and their matched normals.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Metastatic Breast Cancer (INSERM, PLoS Med 2016)

  Whole exome sequencing of 216 tumor/normal (blood) pairs from metastatic breast cancer patients who underwent a biopsy in the context of the SAFIR01/SAFIR02 (Unicancer, France), SHIVA (Institut Curie, France) or MOSCA…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Metastatic Breast Cancer (MSK, Cancer Discovery 2022)

  Targeted Sequencing of 1365 metastatic Breast Cancer tumor/normal pairs via MSK-IMPACT to understand the role of INK4 on CDK4/6 resistance.

  BreastMSK studiesSource code breastPubMed 1

• Metastatic Triple Negative Breast Cancer (UNC Phase II Trial, J Immunother Cancer 2022) - iAtlas Harmonized

  Whole-exome sequencing and neoantigen landscape analysis of 31 patients with pretreated metastatic triple-negative breast cancer (mTNBC) enrolled in a phase II trial (https://clinicaltrials.gov/study/NCT02768701) eval…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Proteogenomic landscape of breast cancer (CPTAC, Cell 2020)

  Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Whole exome sequencing 122 samples. Generated by CPTAC.

  BreastOther published and consortium studiesSource code brcaPubMed 1

• RAD51B Associated Mixed Cancers (MSK, NPJ Breast Cancer 2021)

  Targeted sequencing of 19 samples with RAD51B loss-of-function variants and their matched normals. Samples confer susceptibility to hereditary breast and ovarian cancers, resulting in homologous recombination-deficien…

  BreastTCGA (other releases)Source code mixedPubMed 1

• The Metastatic Breast Cancer Project (Archived, 2020)

  The Metastatic Breast Cancer Project (www.mbcproject.org) is an ongoing patient-driven initiative. This dataset release is derived from 237 samples, including both primary and/or metastatic tumor specimens (FFPE) from…

  BreastOther published and consortium studiesSource code brca

• The Metastatic Breast Cancer Project (Provisional, December 2021)

  The Metastatic Breast Cancer Project (www.mbcproject.org (https://mbcproject.org/)) is an ongoing patient-driven initiative. This dataset release is derived from 379 samples, including both primary and/or metastatic t…

  BreastOther published and consortium studiesSource code brca

• Triple Negative Breast Cancer (DLDCCC, Cancer Discov 2022)

  Whole exome sequencing of 59 pre-treatment and 16 post-treatment triple-negative breast cancer samples and their matched normals as part of micro-scaled proteogenomic analysis to identify markers of chemotherapy resis…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Triple-Negative Breast Cancer (FUSCC, Cell Research 2020)

  Targeted sequencing of 69 refractory metastatic triple-negative breast cancer patients and their matched normal samples as part of the FUTURE trial.

  BreastOther published and consortium studiesSource code brcaPubMed 1